Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 4Unknown 2Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 6Breast 4CNS 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Breast Neoplasms 4Hot Flashes 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Megestrol Acetate × Breast × Clear all
NCT03306472 2024-01-30

PIONEER

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Completed
198 enrolled
Breast

Breast Neoplasms

NCT00005975 2015-11-18

S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
288 enrolled
Breast

Breast Neoplasms, Hot Flashes

NCT00002680 2013-07-24

Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer

Yale University

Phase 2 Completed
40 enrolled
Breast

Breast Neoplasms

NCT01237327 2011-05-06

Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

Pfizer

Phase 3 Completed
84 enrolled 12 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡